• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylcarbamic acid esters

Recent Advances in the Study of tert-Butyl N-(2-Methoxyphenyl)carbamate (CAS: 154150-18-2)

In recent years, tert-Butyl N-(2-Methoxyphenyl)carbamate (CAS: 154150-18-2) has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, known for its versatile applications in organic synthesis and drug development, has been the subject of numerous studies aimed at exploring its potential in medicinal chemistry. The latest research highlights its role as a key intermediate in the synthesis of bioactive molecules, particularly in the development of novel therapeutic agents targeting various diseases.

A recent study published in the Journal of Medicinal Chemistry (2023) investigated the synthetic pathways and biological activities of tert-Butyl N-(2-Methoxyphenyl)carbamate. The researchers employed advanced spectroscopic techniques, including NMR and mass spectrometry, to characterize the compound and its derivatives. The study revealed that this carbamate derivative exhibits promising inhibitory effects on specific enzymatic targets, suggesting its potential as a lead compound for further drug development.

Another significant finding comes from a 2024 paper in Bioorganic & Medicinal Chemistry Letters, which explored the compound's application in the synthesis of kinase inhibitors. The researchers demonstrated that tert-Butyl N-(2-Methoxyphenyl)carbamate serves as a crucial building block in the construction of small-molecule inhibitors targeting protein kinases involved in cancer progression. The study reported a high yield and purity of the final products, underscoring the compound's utility in complex synthetic routes.

In addition to its synthetic applications, recent pharmacological studies have shed light on the compound's potential therapeutic benefits. A preclinical study conducted by a team at the University of Cambridge (2024) evaluated the neuroprotective effects of tert-Butyl N-(2-Methoxyphenyl)carbamate derivatives in models of neurodegenerative diseases. The results indicated that certain derivatives could modulate oxidative stress pathways, offering a novel approach to treating conditions like Alzheimer's disease.

Despite these promising findings, challenges remain in optimizing the compound's pharmacokinetic properties and minimizing potential side effects. Future research directions may focus on structural modifications to enhance bioavailability and target specificity. Collaborative efforts between chemists and biologists will be essential to translate these discoveries into clinically viable therapeutics.

In conclusion, tert-Butyl N-(2-Methoxyphenyl)carbamate (CAS: 154150-18-2) continues to be a valuable compound in chemical biology and pharmaceutical research. Its diverse applications, from synthetic chemistry to drug discovery, highlight its importance in advancing medical science. Ongoing studies are expected to further elucidate its mechanisms of action and expand its therapeutic potential.

• 59255-66-2(TERT-BUTYL 4-ETHOXYPHENYLCARBAMATE)
• 186663-74-1(N-Boc-2-aminophenol)
• 60144-52-7(tert-butyl N-(3-methoxyphenyl)carbamate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)